# Approaching a topological phase transition in Majorana nanowires

Article · Ryan V. Mishmash, David Aasen, Andrew P. Higginbotham, Jason Alicea

- Archive id: arxiv:1601.07908
- Published: 2016-06-08
- Venue: Physical review. B./Physical review. B
- DOI: https://doi.org/10.1103/physrevb.93.245404
- arXiv: https://arxiv.org/abs/1601.07908
- Citations: 56
- Source URL: https://doi.org/10.1103/physrevb.93.245404
- PDF: http://link.aps.org/pdf/10.1103/PhysRevB.93.245404
- Provenance: openalex+arxiv

## Abstract

Recent experiments have produced mounting evidence of Majorana zero modes in nanowire-superconductor hybrids. Signatures of an expected topological phase transition accompanying the onset of these modes nevertheless remain elusive. We investigate a fundamental question concerning this issue: Do well-formed Majorana modes necessarily entail a sharp phase transition in these setups? Assuming reasonable parameters, we argue that finite-size effects can dramatically smooth this putative transition into a crossover, even in systems large enough to support well-localized Majorana modes. We propose overcoming such finite-size effects by examining the behavior of low-lying excited states through tunneling spectroscopy. In particular, the excited-state energies exhibit characteristic field and density dependence, and scaling with system size, that expose an approaching topological phase transition. We suggest several experiments for extracting the predicted behavior. As a useful byproduct, the protocols also allow one to measure the wire's spin-orbit coupling directly in its superconducting environment.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Topological Superconductivity & Majorana Modes](https://space-kitty.com/topics/topological-superconductivity)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.